PF-04995274
CAS No. 1331782-27-4
PF-04995274 ( PF-4995274;TBPT )
Catalog No. M11321 CAS No. 1331782-27-4
PF-04995274 (TBPT) is a novel potent, sellective, partial agonist of 5-HT4 receptor under investigation for neurological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 61 | Get Quote |
|
10MG | 113 | Get Quote |
|
25MG | 186 | Get Quote |
|
50MG | 332 | Get Quote |
|
100MG | 478 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePF-04995274
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-04995274 (TBPT) is a novel potent, sellective, partial agonist of 5-HT4 receptor under investigation for neurological disorders.
-
DescriptionPF-04995274 (TBPT) is a novel potent, sellective, partial agonist of 5-HT4 receptor under investigation for neurological disorders.Alzheimer Disease Phase 1 Discontinued
-
SynonymsPF-4995274;TBPT
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT Receptor
-
Research AreaNeurological Disease
-
IndicationAlzheimer Disease
Chemical Information
-
CAS Number1331782-27-4
-
Formula Weight432.52
-
Molecular FormulaC23H32N2O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1CN(CCC1COC2=NOC3=C2C(=CC=C3)OC4CCOC4)CC5(CCOCC5)O
-
Chemical Name(R)-4-((4-(((4-(Tetrahydrofuran-3-yloxy)-1,2-benzisoxazol-3-yl)oxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sawant-Basak A, et al. J Pharm Sci. 2013 Sep;102(9):3277-93.
molnova catalog
related products
-
CYD-1-79
CYD-1-79 is a potent, selective 5-HT2C receptor positive allosteric modulator (PAM).
-
Molindone hydrochlor...
Molindone is a therapeutic antipsychotic, used in the treatment of schizophrenia, works by blocking the effects of dopamine in the brain, leading to diminished psychoses.
-
2-Bromo-6-methoxynap...
Inhibitors of serotonin reuptake.